Hepatic Arterial Therapy for First-Line Treatment of Unresectable Colorectal Liver Metastases: What We Know in the Wake of Two Recent Randomized Control Trials

Cardiovasc Intervent Radiol. 2017 Feb;40(2):315-317. doi: 10.1007/s00270-016-1469-0. Epub 2016 Sep 20.

Authors

Olaguoke Akinwande^{1

2}, Robert Cg Martin³

Affiliations

¹ Division of Interventional Radiology, Department of Radiology, Johns Hopkins University, Baltimore, MD, USA. gokeakin@gmail.com.
² Division of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 1 Barnes Jewish Hospital Plaza, St. Louis, MO, 63110, USA. gokeakin@gmail.com.
³ Department of Surgical Oncology, University of Louisville, Louisville, KY, USA.

PMID: 27650522
DOI: 10.1007/s00270-016-1469-0

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Aged
Antineoplastic Agents / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chemoembolization, Therapeutic / methods*
Colorectal Neoplasms / pathology*
Female
Hepatic Artery*
Humans
Infusions, Intra-Arterial
Liver Neoplasms / secondary*
Liver Neoplasms / therapy*
Male
Middle Aged
Randomized Controlled Trials as Topic
Survival Analysis
Treatment Outcome

Substances

Antineoplastic Agents